Correlation Between Viking Therapeutics and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on Viking Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Terns Pharmaceuticals.
Diversification Opportunities for Viking Therapeutics and Terns Pharmaceuticals
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Viking and Terns is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viking Therapeutics and Terns Pharmaceuticals
Given the investment horizon of 90 days Viking Therapeutics is expected to generate 1.62 times more return on investment than Terns Pharmaceuticals. However, Viking Therapeutics is 1.62 times more volatile than Terns Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Terns Pharmaceuticals is currently generating about 0.03 per unit of risk. If you would invest 372.00 in Viking Therapeutics on August 27, 2024 and sell it today you would earn a total of 4,887 from holding Viking Therapeutics or generate 1313.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viking Therapeutics vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Viking Therapeutics |
| Terns Pharmaceuticals |
Viking Therapeutics and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viking Therapeutics and Terns Pharmaceuticals
The main advantage of trading using opposite Viking Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Viking Therapeutics vs. Terns Pharmaceuticals | Viking Therapeutics vs. Akero Therapeutics | Viking Therapeutics vs. Madrigal Pharmaceuticals | Viking Therapeutics vs. Sarepta Therapeutics |
| Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings | Terns Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |